Published in Nat Med on September 01, 1999
Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature (2008) 12.45
The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol (2009) 4.36
Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci U S A (2003) 3.75
Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med (2004) 2.94
Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest (2003) 2.37
Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes. Clin Exp Immunol (2007) 2.28
TNF receptor 2 pathway: drug target for autoimmune diseases. Nat Rev Drug Discov (2010) 2.17
Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J Clin Invest (2003) 2.00
Insulin as an autoantigen in NOD/human diabetes. Curr Opin Immunol (2008) 1.95
Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J Clin Invest (2006) 1.88
A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest (2001) 1.70
Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest (2002) 1.65
Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J Exp Med (2003) 1.52
Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes. Diabetes (2010) 1.48
Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity. J Clin Invest (2007) 1.44
Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc Natl Acad Sci U S A (2002) 1.40
Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc Natl Acad Sci U S A (2005) 1.35
Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J Clin Invest (2003) 1.32
Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2K(d) that stimulates CD8 T cells in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (2002) 1.31
CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer. J Exp Med (2002) 1.31
Unconventional recognition of peptides by T cells and the implications for autoimmunity. Nat Rev Immunol (2012) 1.29
Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23. J Clin Invest (2002) 1.26
An update on the use of NOD mice to study autoimmune (Type 1) diabetes. Expert Rev Clin Immunol (2010) 1.13
Autoimmunity in MFG-E8-deficient mice is associated with altered trafficking and enhanced cross-presentation of apoptotic cell antigens. J Clin Invest (2011) 1.11
Tegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans. J Virol (2000) 1.11
Conserved T cell receptor alpha-chain induces insulin autoantibodies. Proc Natl Acad Sci U S A (2008) 1.10
TGF-beta signaling is required for the function of insulin-reactive T regulatory cells. J Clin Invest (2006) 1.09
In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation. Proc Natl Acad Sci U S A (2010) 1.08
Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes. Diabetes (2009) 1.04
Contribution of Fas to diabetes development. Proc Natl Acad Sci U S A (2003) 1.03
Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants. Proc Natl Acad Sci U S A (2001) 1.02
T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes. Immunology (2010) 1.01
HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes. Int J Clin Exp Pathol (2009) 1.00
New methods for assessing T-cell responses. Clin Diagn Lab Immunol (2000) 1.00
Improved assessment of T-cell receptor (TCR) VB repertoire in clinical specimens: combination of TCR-CDR3 spectratyping with flow cytometry-based TCR VB frequency analysis. Clin Diagn Lab Immunol (2002) 0.98
Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides. Nat Med (2012) 0.97
Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers. Proc Natl Acad Sci U S A (2000) 0.97
Gamma delta T cell receptors confer autonomous responsiveness to the insulin-peptide B:9-23. J Autoimmun (2010) 0.96
B-cell cross-presentation of autologous antigen precipitates diabetes. Diabetes (2012) 0.96
Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4*04 anti-insulin B:9-23 alpha chains. J Autoimmun (2009) 0.94
Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse. J Autoimmun (2009) 0.94
The role of the intestinal microbiota in type 1 diabetes mellitus. Nat Rev Endocrinol (2016) 0.93
T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading. J Clin Immunol (2004) 0.91
The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes. J Autoimmun (2015) 0.91
Central and peripheral autoantigen presentation in immune tolerance. Immunology (2004) 0.90
Antigen-based immune therapeutics for type 1 diabetes: magic bullets or ordinary blanks? Clin Dev Immunol (2011) 0.90
Protection of islet grafts through transforming growth factor-β-induced tolerogenic dendritic cells. Diabetes (2013) 0.89
Dendritic cell-directed CTLA-4 engagement during pancreatic beta cell antigen presentation delays type 1 diabetes. J Immunol (2010) 0.88
Enumerating autoreactive T cells in peripheral blood: a big step in diabetes prediction. J Clin Invest (2003) 0.88
Human CD8 responses to a complete epitope set from preproinsulin: implications for approaches to epitope discovery. J Clin Immunol (2008) 0.87
Microbial antigen mimics activate diabetogenic CD8 T cells in NOD mice. J Exp Med (2016) 0.87
Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice. J Clin Invest (2011) 0.86
A distinct role of CD4+ Th17- and Th17-stimulated CD8+ CTL in the pathogenesis of type 1 diabetes and experimental autoimmune encephalomyelitis. J Clin Immunol (2011) 0.86
Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells. J Immunol Methods (2008) 0.85
Matrix metalloproteinases, T cell homing and beta-cell mass in type 1 diabetes. Vitam Horm (2009) 0.85
Ins2 deficiency augments spontaneous HLA-A*0201-restricted T cell responses to insulin. J Immunol (2009) 0.85
Distortion of the Major Histocompatibility Complex Class I Binding Groove to Accommodate an Insulin-derived 10-Mer Peptide. J Biol Chem (2015) 0.84
The immunotherapeutic potential of dendritic cells in type 1 diabetes. Clin Exp Immunol (2010) 0.84
Compensatory mechanisms allow undersized anchor-deficient class I MHC ligands to mediate pathogenic autoreactive T cell responses. J Immunol (2014) 0.84
Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment. J Autoimmun (2009) 0.84
Selective immunotargeting of diabetogenic CD4 T cells by genetically redirected T cells. Immunology (2014) 0.84
Mechanistic basis of immunotherapies for type 1 diabetes mellitus. Transl Res (2013) 0.84
Novel approaches for identifying target antigens of autoreactive human B and T cells. Semin Immunopathol (2009) 0.83
A translatable molecular approach to determining CD8 T-cell epitopes in TMEV infection. Hum Immunol (2008) 0.83
Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease. Clin Exp Immunol (2007) 0.82
CD86 has sustained costimulatory effects on CD8 T cells. J Immunol (2007) 0.82
The pathogenicity of self-antigen decreases at high levels of autoantigenicity: a computational approach. Int Immunol (2010) 0.82
Antigen-dependent immunotherapy of non-obese diabetic mice with immature dendritic cells. Clin Exp Immunol (2010) 0.82
Critical roles of CD30/CD30L interactions in murine autoimmune diabetes. Clin Exp Immunol (2003) 0.81
Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans? Rev Diabet Stud (2004) 0.81
Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword. J Clin Invest (2003) 0.81
The role of Gr1+ cells after anti-CD20 treatment in type 1 diabetes in nonobese diabetic mice. J Immunol (2011) 0.81
Primer: immunity and autoimmunity. Diabetes (2008) 0.80
Retroviral and lentiviral vectors for the induction of immunological tolerance. Scientifica (Cairo) (2012) 0.80
Inhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine Production. PLoS One (2016) 0.79
Etiopathogenesis of insulin autoimmunity. Anat Res Int (2012) 0.79
Glucagon-reactive islet-infiltrating CD8 T cells in NOD mice. Immunology (2015) 0.78
Functional inhibition related to structure of a highly potent insulin-specific CD8 T cell clone using altered peptide ligands. Eur J Immunol (2008) 0.77
Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes. J Immunol (2016) 0.77
Targeted immune interventions for type 1 diabetes: not as easy as it looks! Curr Opin Endocrinol Diabetes Obes (2014) 0.77
Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect. Int Immunol (2010) 0.77
The use of peptide-major-histocompatibility-complex multimers in type 1 diabetes mellitus. J Diabetes Sci Technol (2012) 0.77
Proteasomal Degradation of Proinsulin Requires Derlin-2, HRD1 and p97. PLoS One (2015) 0.77
T cells recognizing a peptide contaminant undetectable by mass spectrometry. PLoS One (2011) 0.77
Advances in cellular therapy for the treatment of thyroid cancer. J Oncol (2010) 0.76
Making the most of major histocompatibility complex molecule multimers: applications in type 1 diabetes. Clin Dev Immunol (2012) 0.76
Spotting a killer's target in autoimmune diabetes. Nat Med (1999) 0.75
Adoptive Transfer of mRNA-Transfected T Cells Redirected against Diabetogenic CD8 T Cells Can Prevent Diabetes. Mol Ther (2017) 0.75
Interferon gamma Limits Diabetogenic CD8 T-Cell Effector Responses in Type-1 Diabetes. Diabetes (2016) 0.75
Detection of vasostatin-1-specific CD8(+) T cells in non-obese diabetic mice that contribute to diabetes pathogenesis. Clin Exp Immunol (2016) 0.75
Autoimmune diabetes: ongoing development of immunological intervention strategies targeted directly against autoreactive T cells. Rev Diabet Stud (2004) 0.75
Grafts of supplementary thymuses injected with allogeneic pancreatic islets protect nonobese diabetic mice against diabetes. Proc Natl Acad Sci U S A (2002) 0.75
Generation of a cholangiocyte-specific cDNA expression library for the identification of B and T cell autoantigens in murine biliary disease. Hepatol Res (2012) 0.75
Proinsulin Expression Shapes the TCR Repertoire but Fails to Control the Development of Low-Avidity Insulin-Reactive CD8+ T Cells. Diabetes (2016) 0.75
Perinatal tolerance to proinsulin is sufficient to prevent autoimmune diabetes. JCI Insight (2016) 0.75
Targeted suppression of autoreactive CD8(+) T-cell activation using blocking anti-CD8 antibodies. Sci Rep (2016) 0.75
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (1997) 23.92
Monoclonal antibodies to nucleic acid-containing cellular constituents: probes for molecular biology and autoimmune disease. Proc Natl Acad Sci U S A (1981) 10.72
CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XII. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PREVENTION AND ATTENUATION OF MEASLES. J Clin Invest (1944) 10.24
Innate immunity: the virtues of a nonclonal system of recognition. Cell (1997) 9.42
Phylogenetic perspectives in innate immunity. Science (1999) 9.42
MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell (1998) 8.73
STUDIES ON THE PLASMA PROTEINS. V. THE EFFECT OF CONCENTRATED SOLUTIONS OF HUMAN AND BOVINE SERUM ALBUMIN ON BLOOD VOLUME AFTER ACUTE BLOOD LOSS IN MAN. J Clin Invest (1943) 8.26
The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. Annu Rev Immunol (1986) 6.23
Sequence analysis of peptides bound to MHC class II molecules. Nature (1991) 5.99
Innate immunity: impact on the adaptive immune response. Curr Opin Immunol (1997) 5.62
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol (1984) 5.51
Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol (2000) 5.45
HISTOLOGICAL AND SEROLOGICAL SEQUENCES IN EXPERIMENTAL HYPERSENSITIVITY. J Exp Med (1947) 5.11
Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med (1993) 4.99
Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity (1998) 4.85
Early programming of T cell populations responding to bacterial infection. J Immunol (2000) 4.57
Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sci U S A (1992) 3.97
Specificity and function of T cells bearing gamma delta receptors. Immunol Today (1988) 3.93
Monoclonal antibody against an Ir gene product? J Exp Med (1980) 3.88
LacZ inducible, antigen/MHC-specific T cell hybrids. Int Immunol (1994) 3.47
Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J Exp Med (1990) 3.45
The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature (2001) 3.45
Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell (2001) 3.44
On the complexity of self. Nature (1991) 3.43
Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med (1996) 3.36
Two different VH gene products make up the T-cell receptors. Scand J Immunol (1976) 3.32
T cell affinity maturation by selective expansion during infection. J Exp Med (1999) 3.08
The gamma globulins. 3. The antibody deficiency syndromes. N Engl J Med (1966) 3.03
Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science (2001) 3.00
Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition. Immunity (1999) 2.89
Intestinal intraepithelial lymphocytes are a distinct set of gamma delta T cells. Nature (1988) 2.89
Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted. Nature (1981) 2.85
Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells. Cell (1991) 2.79
Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity (1995) 2.77
Evidence for an immunoglobulin-dependent antigen-specific helper T cell. Proc Natl Acad Sci U S A (1977) 2.72
Hemispherical variations in seismic velocity at the top of the Earth's inner core. Nature (2001) 2.67
Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med (1991) 2.60
Surgical complications secondary to decompressive craniectomy in patients with a head injury: a series of 108 consecutive cases. Acta Neurochir (Wien) (2008) 2.59
The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site. Immunol Rev (1987) 2.56
The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J Immunol (1987) 2.55
TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell (1993) 2.43
Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J Exp Med (1992) 2.42
Intracellular calcium dependence of gene expression in single T lymphocytes. Proc Natl Acad Sci U S A (1994) 2.42
CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med (1996) 2.42
Receptor-directed focusing of lymphokine release by helper T cells. Nature (1988) 2.41
Implantation of a foetal thymus, restoring immunological competence in a patient with thymic aplasia (Digeorge's syndrome). Lancet (1968) 2.40
Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science (1996) 2.36
Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells. J Immunol (1984) 2.35
Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection. J Exp Med (1998) 2.32
Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene (2008) 2.31
Do B cells drive the diversification of immune responses? Immunol Today (1993) 2.31
The role of Fas in autoimmune diabetes. Cell (1997) 2.30
Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation. J Immunol (1989) 2.24
Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. Brain (2000) 2.23
Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity (1999) 2.18
ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev (1999) 2.17
Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene. Proc Natl Acad Sci U S A (1991) 2.16
Rearranged beta T cell receptor genes in a helper T cell clone specific for lysozyme: no correlation between V beta and MHC restriction. Cell (1985) 2.14
Cutting edge: antigen-independent CD8 T cell proliferation. J Immunol (2001) 2.09
Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci U S A (1996) 2.06
A novel MHC class II epitope expressed in thymic medulla but not cortex. Nature (1989) 2.06
Coclustering of CD4 (L3T4) molecule with the T-cell receptor is induced by specific direct interaction of helper T cells and antigen-presenting cells. Proc Natl Acad Sci U S A (1987) 2.04
Evidence for a physical association of CD4 and the CD3:alpha:beta T-cell receptor. Nature (1987) 2.01
The specific direct interaction of helper T cells and antigen-presenting B cells. Proc Natl Acad Sci U S A (1986) 1.98
An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature (1989) 1.97
The molecular and functional characterization of a dominant minor H antigen, H60. J Immunol (1998) 1.97
Monoclonal antibody detection of a major self peptide. MHC class II complex. J Immunol (1992) 1.94
Innate immune recognition and control of adaptive immune responses. Semin Immunol (1998) 1.92
T-cell alpha beta + and gamma delta + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium. Proc Natl Acad Sci U S A (1996) 1.92
Breaking T cell tolerance with foreign and self co-immunogens. A study of autoimmune B and T cell epitopes of cytochrome c. J Immunol (1992) 1.89
Blood and Blood Derivatives-A New Public Health Field. Am J Public Health Nations Health (1946) 1.86
Recognition of a self major histocompatibility complex TL region product by gamma delta T-cell receptors. Proc Natl Acad Sci U S A (1989) 1.84
Immunodominant and subdominant CTL responses to Listeria monocytogenes infection. J Immunol (1997) 1.83
Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure. J Infect Dis (2008) 1.82
Cellular cooperation during in vivo anti-hapten antibody responses. I. The effect of cell number on the response. J Immunol (1975) 1.81
IgG anti-DNA autoantibodies within an individual autoimmune mouse are the products of clonal selection. J Immunol (1989) 1.81
An evaluation of the infraclavicular block via a modified approach of the Raj technique. Anesth Analg (2001) 1.78
Screening for inherited diseases. N Engl J Med (1971) 1.73
An ancient system of host defense. Curr Opin Immunol (1998) 1.73
Co-stimulation of murine CD4 T cell growth: cooperation between B7 and heat-stable antigen. Eur J Immunol (1992) 1.72
H2-M3-restricted T cells in bacterial infection: rapid primary but diminished memory responses. J Exp Med (1999) 1.70
Frontiers of the immune system. Nature (1988) 1.70
The response in vitro of human lymphocytes to phytohemagglutinin and to antigens after fractionation on discontinuous density gradients of albumin. Cell Immunol (1970) 1.70
Activity of migration inhibitory factor in the absence of antigen. J Immunol (1972) 1.68
Cloned helper T cells can kill B lymphoma cells in the presence of specific antigen: Ia restriction and cognate vs. noncognate interactions in cytolysis. Eur J Immunol (1984) 1.66
Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature (1992) 1.65
Absence of an antigen-specific helper T cell required for the expression of the T 15 idiotype in mice treated with anti-mu antibody. Eur J Immunol (1980) 1.62
Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol (1990) 1.62
CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXVI. INACTIVATION OF THE VIRUS OF HOMOLOGOUS SERUM HEPATITIS IN SOLUTIONS OF NORMAL HUMAN SERUM ALBUMIN BY MEANS OF HEAT. J Clin Invest (1948) 1.60